As of 6 Oct 2026, Himalaya Nutravedics India Ltd share price is ₹128.70. The stock opened at ₹128.70 and had closed at ₹122.60 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹111.00 and a high of ₹123.90. In terms of performance, Himalaya Nutravedics India Ltd share price has increased by 4.97% over the past six months and has decreased by 0.24% over the last year.
Himalaya Nutravedics Stock Price Chart
Himalaya Nutravedics India Ltd Overview
About Himalaya Nutravedics
Himalaya Nutravedics India is engaged in the manufacturing, marketing and distribution of Ayurvedic and Nutraceutical formulations in India and also undertakes third-party contract manufacturing for other Ayurvedic and Nutraceutical companies. Our Company manufactures a diversified portfolio comprising classical (Shastric) Ayurvedic formulations, which are based on compositions and processes described in traditional Ayurvedic texts such as Charaka Samhita, Sushruta Samhita, Ashtanga Hridaya, Bhaishajya Ratnavali and other recognized Ayurvedic compendia, proprietary Ayurvedic formulations and Nutraceutical products across multiple dosage forms, including soft gelatin capsules, hard gelatin capsules, tablets, Liquid orals, Medicated oils.
Himalaya Nutravedics India Ltd Historical Performance
Himalaya Nutravedics India Ltd Fundamentals
Himalaya Nutravedics India Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|
| Revenue | 43.12 | 21.00 | 14.43 | 2.05 |
| EBITDA | 8.16 | 2.99 | 0.93 | 0.24 |
| Net Profit | 7.39 | 2.23 | 0.43 | 0.10 |
| EPS | 11.72 | 5.57 | 5.13 | 1.19 |
Himalaya Nutravedics India Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 114.87 |
| Resistance 1 (R1) | 126.47 |
| Pivot Point | 118.73 |
Himalaya Nutravedics India Ltd Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Rohit Asawa | Chairman |
| Divya Asawa | Non Executive Director |
| Abhisheak Dhoot | Independent Director |
Himalaya Nutravedics India Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,787.40-0.76% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,167.50-0.88% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,732.80-0.72% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Himalaya Nutravedics India Ltd today is ₹128.70 on NSE and ₹128.70 on BSE.
- The 52-week high of Himalaya Nutravedics India Ltd is ₹123.90, while the 52-week low is ₹111.00.
- The current market capitalisation of Himalaya Nutravedics India Ltd is approximately ₹108 crore.
- The P/E (Price-to-Earnings) ratio of Himalaya Nutravedics India Ltd is 0.00. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Himalaya Nutravedics India Ltd is 2.52. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Himalaya Nutravedics India Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Himalaya Nutravedics on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Himalaya Nutravedics India Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Himalaya Nutravedics India Ltd comprises different categories of shareholders. As of Sept 2026, the shareholding is approximately 68.13% promoters, 7.54% FIIs, 0.00% DIIs, and 14.68% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
